Sinovac's Credit Rating Upgraded to AAZ, Second Highest Rating
Obtains 10 Million RMB Commercial Bank Loan With Interest Payment Subsidy BEIJING, Oct. 9 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, announced today that the Beijing Zhongguancun Enterprises Credit Promotion Association at the Zhonggua...
Sinovac Initiates Development of Vaccine Against Hand, Foot, and Mouth Disease
BEIJING, Sept. 23 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading developer and provider of vaccines in China, today announced it has initiated development of a vaccine human enterovirus 71, EV 71, which causes hand, foot, and mouth disease (or HFMD). In collaboration with Chi...
Sinovac Biotech Increases Ownership Position in its Operating Subsidiary Sinovac Beijing
BEIJING, Sept. 22 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading developer and provider of vaccines in China, today announced the increase of its ownership position in Sinovac Biotech Co., Ltd. (or Sinovac Beijing), its Beijing-based subsidiary and main operating entity. ...
Sinovac Biotech Holds 2007 Annual General Meeting
BEIJING, Sept. 18 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that its Annual General Meeting originally scheduled for September 4, 2008 was held two weeks later, on September 18, 2008. During the September 18, 2008 ...
Sinovac to Present at the 2008 UBS Global Life Sciences Conference
BEIJING, Sept. 17 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, announced today that Mr. Weidong Yin, Chairman, president & CEO, will present at 2008 UBS Global Life Sciences Conference, at Grant Hyatt Beijing Hotel in New York City. The Pr...
Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine
BEIJING, Sept. 16 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced the initiation of clinical trials in Ukraine for its inactivated hepatitis A vaccine, Healive, in September, 2008. The trials are being conducted by Biolik Biophar...
Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
BEIJING, Sept. 11 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced the market launch of Anflu(R), a seasonal influenza vaccine, for 2008-2009 Flu Season. Developed and manufactured by Sinovac, Anflu(R) is the only split influenz...
Sinovac Adjourns Annual General Meeting
BEIJING, Sept. 4 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that its Annual General Meeting originally scheduled for September 4, 2008 has been adjourned to September 18, 2008. At the September 4, 2008 Annual General Mee...
Sinovac to Present at the Susquehanna Financial Group’s Second Annual Beijing Management Summit Conference
BEIJING, Sept. 1 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, announced today that Mr. Weidong Yin, Chairman, President and CEO, is scheduled to present at the Susquehanna Financial Group’s Second Annual Beijing Management Summit Conference...
Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results
-- Conference Call on Wednesday, August 13, 2008 at 9:00 a.m. ET -- BEIJING, Aug. 13 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading developer and provider of vaccines in China, today announced the Company's financial results for the six and three-month periods ended Ju...
Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
BEIJING, Aug. 11 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, announced today that it will hold its 2007 Annual Meeting of Shareholders on Thursday, September 4, 2008 at 9:00 a.m. Beijing Time. The meeting will be held concurrently at No. ...
Sinovac to Host Conference Call to Report Second Quarter 2008 Financial Results
BEIJING, Aug. 7 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, today announced that it will host a conference call on Wednesday, August 13, 2008 at 9:00 a.m. ET to review the Company’s second quarter financial results for the period ended Jun...
Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
BEIJING, June 30 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced the initiation of volunteer enrollment in its Phase II clinical trial for its split pandemic influenza vaccine. The preliminary results from this study are expecte...
Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas
BEIJING, June 16 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that the Shanxi Center for Disease Control and Prevention (CDC) ordered 257,100 doses of Healive(R), the inactivated hepatitis A vaccine manufactured by Sinovac. O...
Sinovac Delivers 80,000 Doses of Bilive to Gansu Earthquake Disaster Area
BEIJING, June 11 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that the Municipal Health Bureau and Municipal Center for Disease Control purchased 80,000 doses of Bilive, the combined inactivated hepatitis A and B vaccine ma...
Sinovac Receives RMB 20 Million Purchase Order for Healive from China's Ministry of Health to Vaccinate Earthquake Victims
BEIJING, May 27 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that the Ministry of Health has purchased approximately RMB 20 million (US$2.86 million) of the Company's inactivated hepatitis A vaccine, Healive(R), to vaccinate pe...
Sinovac Provides Support to China's Ministry of Health to Aid Earthquake Victims
BEIJING, May 22 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that it is providing immediate support to China's Ministry of Health following the May 12th earthquake in Sichuan province. The assistance is intended to support dise...
Sinovac Reports First Quarter 2008 Unaudited Financial Results
-- Conference Call on Friday, May 16, 2008 at 9:00 a.m. ET -- BEIJING, May 16 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading developer and provider of vaccines in China, today announced the Company's unaudited interim consolidated financial statements for the three-month...
Sinovac to Host Conference Call to Report First Quarter 2008 Financial Results
Beijing, May 15 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that it will host a conference call on Friday, May 16, 2008 at 9:00 a.m. ET to review the Company’s first quarter financial results for the period ended March 31,...
Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
BEIJING, May 7 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that Mr. Weidong Yin, CEO, and Ms. Helen Yang, International Business Manager, are scheduled to present at the Brean Murray, Carret & Co. All-Cap All-China Confere...
